Rojas CK

Idioma: Español
Referencias bibliográficas: 19
Paginas: 405-409
Archivo PDF: 347.09 Kb.

RESUMEN

Los nódulos tiroideos son comunes y presentan un 5% de riesgo de malignidad. El reto en el manejo es identificar los nódulos benignos y diagnosticar y tratar las enfermedades malignas de tiroides en una etapa temprana. El manejo actual incluye inicialmente mediciones de TSH, US y BAAF (en caso de ser necesario BAAF guiada por US) ha demostrado ser práctico, eficiente y rentable. El resultado de la BAAF determina cual tratamiento es el más efectivo ya sea cirugía, I¹³¹ o nuevas opciones terapéuticas como la IPE.

REFERENCIAS (EN ESTE ARTÍCULO)

1. AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006;12(1):63–102.

2. Belfiore A, Giuffrida D, La Rosa GL, et al. High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol (Copenh) 1989;121(2):197–202.

3. British Thyroid Association. Guidelines for the management of thyroid cancer in adults. London: Royal College of Physicians of London and the British Thyroid Association; 2001. [cited 2005 Aug 2]. Available at: http://www.british-thyroid-association.org/complete%20guidelines.pdf.

4. CooperDS, Doherty GM, Haugen BR, et al, The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109–42.

5. Filetti S, Durante C, Torlontano M. Nonsurgical approaches to the management of thyroid nodules. Nat Clin Pract Endocrinol Metab 2006;2(7):384–94.

6. Gharib H, Papini E. Thyroid Nodules: Clinical Importance, Assessment and Treatment. Endocrinol Metab Clin N Am 36 (2007): 707-735.

7. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc 1994;69(1):44–9.

8. Goellner JR, Gharib H, Grant CS, et al. Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol 1987;31(5):587–90.

9. Guglielmi R, Pacella CM, Bianchini A, et al. Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid 2004;14(2):125–31.

10. Hegedus L. Clinical practice: the thyroid nodule. N Engl J Med 2004;351(17):1764–71.

11. Mandel SJ. Diagnostic use of ultrasonography in patients with nodular thyroid disease. Endocr Pract 2004;10(3):246–52.

12. Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clini-cally normal thyroid glands. J Clin Endo-crinol Metab 1955;15(10):1270–80.

13. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87(5):1941–6.

14. Papini E, Guglielmi R, Bizzarri G, et al. Ultrasound-guided laser thermal ablation for treatment of benign thyroid nodules. Endocr Pract 2004;10(3):276–83.

15. Ross DM. Diagnostic approach to and treatment of thyroid nodules. I. In: Rose BD, editor. Wellesley (MA): UpToDate; 2005.

16. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126(3): 226–31.

17. Thyroid Carcinoma Task Force, American Association of Clinical Endocrinologists, American College of Endocrinology. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract 2001;7(3):202–20.

18. Tollin SR, Fallon EF, Mikhail M, et al. The utility of thyroid nuclear imaging and other studies in the detection and treatment of underlying thyroid abnormalities in patients with endogenous subclinical thyrotoxicosis. Clin Nucl Med 2000;25(5):341–7.

19. Vander JB, Gaston EA, Dawber TR. The 19. significance of nontoxic thyroid nodules: final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 1968;69(3):537–40.